Skip to content
Research/Peptides/CJC-1295

CJC-1295

compound

preliminary evidencePublic

Modified GRF 1-29 with DAC modification. GHRH analog - shorter half-life (~30 min), allows more natural pulsatile GH pattern. Combined with Ipamorelin for synergistic effects.

Category: Peptides·Updated 5/20/2026
OverviewScienceClinicalSafetyPapersProtocolsOutcomes

CJC-1295

Modified GRF 1-29 with DAC modification. GHRH analog - shorter half-life (~30 min), allows more natural pulsatile GH pattern. Combined with Ipamorelin for synergistic effects.

ScienceComing soon
ClinicalComing soon
SafetyComing soon
PapersComing soon
ProtocolsComing soon
OutcomesComing soon